首页> Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc> Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.

导出 OA

翻译打印收藏纠错

第一作者： Thai H,Ho

第一单位： Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.;Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.

作者： Thai H,Ho ^[1] ; Payal,Kapur ^[2] ; Richard W,Joseph ^[3] ; Daniel J,Serie ^[4] ; Jeanette E,Eckel-Passow ^[5] ; Pan,Tong ^[6] ; Jing,Wang ^[6] ; Erik P,Castle ^[7] ; Melissa L,Stanton ^[8] ; John C,Cheville ^[9] ; Eric,Jonasch ^[10] ; James,Brugarolas ^[11] ; Alexander S,Parker ^[4]

作者单位： Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.;Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. ^[1] Departments of Pathology and Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.;Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[2] Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA. ^[3] Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA. ^[4] Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. ^[5] Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[6] Department of Urology, Mayo Clinic Hospital, Phoenix, AZ, USA. ^[7] Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA. ^[8] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. ^[9] Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[10] Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.;Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[11]